Therefore, targeting T cells with anti-PD-1/PD-L1 antibodies may possibly overcome the escape mechanisms employed by malignancies and restore the equilibrium of the immune system or even facilitate tumor destruction [3, 4]. The gene discussed is PDCD1; the disease is neoplasm.